In the News

trialsitenews, Aug. 28, 2025, 12:30 p.m. September is Alzheimer’s Awareness Month, a time to reflect on the devastating impact of Alzheimer’s disease and the urgent need for better treatments and care. More than 6 million Americans are living with Alzheimer’s, a number expected to climb steeply in the coming decades. As the need grows, so […]

22 Aug 2025 The current Alzheimer’s disease therapeutic antibodies carry a sizable risk of ARIA, especially for APOE4 carriers. Researchers believe the future of amyloid immunotherapies lies in targeted brain delivery that bypasses the larger blood vessels prone to this side effect, and several companies are working on this. At the Alzheimer’s Association International Conference, […]

A groundbreaking mobile research unit made its West Coast debut in Mission Viejo on Saturday, August 9, at Mount of Olives Church. The Healthy Brain Clinic launched the unit to improve access to brain health education and services. With 12% of Californians currently living with Alzheimer’s disease, the mobile unit aims to lower barriers for […]

Axiom Brain Health recently launched a new Florida-based mobile research unit that will tour the state to improve accessibility to brain health education and services in Tampa. A ribbon cutting was held Aug. 6 at the New Mt. Zion Baptist Church in Tampa featuring Pastor Larry Roundtree, the experts from Axiom Brain Health, and The […]

The Global Alzheimer’s Platform Foundation (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) have released the Bio?Hermes?001 dataset — described as the most comprehensive biomarker dataset in Alzheimer’s research history. The release of Bio?Hermes?001 marks a pivotal moment in Alzheimer’s research: a first?of?its?kind dataset blending biomarker, cognitive, retinal, and speech data across a deeply diverse cohort. Now available to scientists worldwide, […]

OliverBlake, Sunday, Jul 27, 2025 4:21 pm ETThe global Alzheimer’s disease market is a high-stakes arena where innovation and precision collide. With over 60 million people affected worldwide and a projected $19.44 billion market size by 2030, the race to develop disease-modifying therapies (DMTs) and diagnostics is intensifying. Roche, a pharmaceutical giant with a legacy […]

June 30, 2025 | 1 min read The global alzheimer’s disease diagnostics market size is calculated at USD 8.95 billion in 2024, grows to USD 9.94 billion in 2025, and is projected to reach around USD 25.53 billion by 2034, growing at a CAGR of 11.05% from 2025 to 2034. Rising regulatory approvals, innovative product launches, research funding […]

by: Alex Torres-Perez, Posted: Jun 30, 2025 CENTRAL FALLS, R.I. (WPRI) — Central Falls-based Progreso Latino has been awarded the Global Alzheimer’s Platform Foundation’s prestigious Citizen Scientist Cultivator Award for its work bridging barriers to get more Hispanic people involved in Alzheimer’s studies, which could help millions in the future. Studies show Hispanics are 1.5 times more […]

This article was originally published in the Washington Examiner by Elaine Mallon Jason Raubach was diagnosed at 50 years old with early-onset Alzheimer’s disease — a diagnosis that affects nearly 200,000 Americans. He received the diagnosis in 2018, completely upending life for his family. His youngest child was just a freshman in high school. “It’s like somebody grabs you by […]

Posted on the Chicago Tribune on June 9, 2025. After several unexplained memory slips, there came a day when my wife, Geri, didn’t recognize her own face in the mirror. That’s when we knew it was time for her to get checked out. It was 2012, and Alzheimer’s was a feared diagnosis. At the time, […]

May 10, 2025 Chicago Bulls Guard Jahmir Young (left) Senator Mattie Hunter (middle) and Dr. Rany Aburashed, CEO of Neurogen Biomarking (right) rallied over 400 community members during a free Brain Health Day sponsored by Neurogen at Insight Hospital (Photo Provided).  On Saturday, more than 400 community members participated in Capturing Memories: A Free Brain Health […]

BY NANCY SCHIMELPFENING MAY 12, 2025 3:30 PM EST Alzheimer’s disease is a form of dementia that affects memory, thinking, and behavior severely enough to interfere with daily life. While certain treatments may slow its progression, there is currently no cure. (Here are some warning signs of Alzheimer’s disease you should never ignore.) According to The South […]

In November, Texans will vote on whether to invest $3 billion into dementia research. Texas ranks third in the nation for rates of dementia. “It doesn’t just affect the patient, it affects the entire family,” El Faro Health and Therapeutics Primary Investigator Dr. James Falcon said. In Starr County, you don’t have to look very […]

By  Diana Bruk Published May 1, 2025, 3:10 p.m. A county in southern Texas, near the US-Mexico border, is suffering from a bit of an epidemic. Starr County has emerged as a national hot spot — not for tourism or industry, but for having one of the highest rates of dementia in the country. Roughly one in five seniors […]

Published: 01:45 EDT, 1 May 2025 | Updated: 08:26 EDT, 1 May 2025 While it might appear like just another sleepy border town, Rio Grande City in southern Texas has a dark secret. The community of just over 15,000 residents has one of the highest dementia rates in America.  One in four people here over the age of 65 have it compared to around […]

BY  SETH VOORHEES OSWEGO | spectrumlocalnews OWEGO, N.Y. — Nearly seven million Americans live with Alzheimer’s disease, and according to the National Institutes of Health, the number could grow by 50% by 2060. It’s a stunning number, but researchers say they’re making great progress in understanding and preventing the disease, which affects memory, thinking and behavior. An author and […]

iLoF, the leading innovator in AI-powered photonics platforms for personalised medicine, announces today a strategic investment from Hamamatsu, the world expert in the development and manufacturing of photonics devices and systems for medical optics and biophotonics, to further its mission of transforming healthcare and driving innovation in medicine. LONDON, Oct. 22, 2024 /PRNewswire/ — iLoF, the leading company […]

*”This story reposted in its entirely in the original posted language”*En un evento celebrado en la Conferencia de Optimización de Sitios GAP-Net 2025 en Miami, Florida, la Global Alzheimer’s Platform Foundation® reconoció a Dilenia Cruz como una de las figuras clave en la lucha contra enfermedades neurodegenerativas al otorgarle el prestigioso título de Citizen Scientist Cultivator […]

Allison “Allie” Signorelli started sharing her journey with young-onset Parkinson’s on Instagram to create a community with others. Since then, she has joined research studies and teamed up with advocates to spread awareness. News4’s Molette Green reports.  View segment here: https://www.nbcwashington.com/community/in-the-community/arlington-woman-shares-young-onset-parkinsons-journey-and-advocates-for-research/3876476

A blood-based diagnostic test for neurodegenerative diseases is a global priority By Zivjena Vucetic 03/21/2025 As the global population ages, the incidence of neurodegenerative diseases such as Alzheimer’s disease (AD) is rapidly increasing. By 2050, the global population of people over the age of 60 is expected to double, reaching 2.1 billion individuals, while those over 80 […]

By Christopher Placek – Daily Herald More than a decade after hosting clinical trials for two medications now commonly used to slow the progression of Alzheimer’s disease, researchers at Ascension Alexian Brothers hospital in Elk Grove Village are now studying potential new treatments to address the neurological disorder. “We have these two very interesting studies […]

By Aging Research, Published March 10, 2025 Aging Research The Alliance for Aging Research, the Partnership to Fight Chronic Disease (PFCD), and the Global Alzheimer’s Platform Foundation (GAP) submitted comments today on both of the recently issued draft guidances on accelerated approval—Expedited Programs for Serious Conditions—Accelerated Approval of Drugs and Biologics (hereafter the “Programmatic Guidance”) and Accelerated Approval and Considerations for […]

John Peters said the clinical trial he participated in at the Kawartha Centre gave him parts of his life back. John Peters wasn’t surprised when he started having trouble remembering things — he knew both his father and grandfather battled with Alzheimer’s. “The only big difference was I never smoked,” said Peters. “I was not […]

By Allie Corey Published  March 11, 2025 6:01pm EDT FOX 13 News Ironman athlete with Alzheimer’s sets a new goal FOX 13’s Allie Corey highlights Scott Berkheiser, who is inspiring others by competing in the Ironman Triathlon despite being diagnosed with early-onset Alzheimer’s at 55 years old. The Brief TAMPA, Fla. – The Ironman Triathlon is a grueling […]